Literature DB >> 18492563

Origin, regulation and physiological function of intestinal oeosinophils.

Patricia C Fulkerson1, Marc E Rothenberg.   

Abstract

Oeosinophils are pleiotropic multi-functional leukocytes that are typically associated with the initiation and propagation of inflammatory responses, particularly helminth infection and allergic disease. However, expanding evidence supports a broader role for oeosinophils in homoeostatic function and organ development and modulation of local immune responses via interaction with other effector cells. In this review, the biology of oeosinophils in the healthy gut is summarised. In particular, the molecular steps involved in oeosinophil development and trafficking are described, with special attention to the important role of the transcription factor GATA-1, the oeosinophil-selective cytokine IL-5 and the eotaxin subfamily of chemokines. In addition, the regulation of oeosinophil survival by inhibitory and death receptors and the expanding role for oeosinophils in health and disease are reviewed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492563      PMCID: PMC2706084          DOI: 10.1016/j.bpg.2007.10.023

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  99 in total

Review 1.  Lymphocyte trafficking and regional immunity.

Authors:  E C Butcher; M Williams; K Youngman; L Rott; M Briskin
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

Review 2.  Transcription factors, normal myeloid development, and leukemia.

Authors:  D G Tenen; R Hromas; J D Licht; D E Zhang
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

3.  Eotaxin is required for the baseline level of tissue eosinophils.

Authors:  A N Matthews; D S Friend; N Zimmermann; M N Sarafi; A D Luster; E Pearlman; S E Wert; M E Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.

Authors:  A Shinkai; H Yoshisue; M Koike; E Shoji; S Nakagawa; A Saito; T Takeda; S Imabeppu; Y Kato; N Hanai; H Anazawa; T Kuga; T Nishi
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

5.  Fundamental signals that regulate eosinophil homing to the gastrointestinal tract.

Authors:  A Mishra; S P Hogan; J J Lee; P S Foster; M E Rothenberg
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

6.  Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3.

Authors:  M Kitaura; N Suzuki; T Imai; S Takagi; R Suzuki; T Nakajima; K Hirai; H Nomiyama; O Yoshie
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

Review 7.  The role of eosinophils in pulmonary fibrosis (Review).

Authors:  M Gharaee-Kermani; S H Phan
Journal:  Int J Mol Med       Date:  1998-01       Impact factor: 4.101

8.  Nerve growth factor is preformed in and activates human peripheral blood eosinophils.

Authors:  A Solomon; L Aloe; J Pe'er; J Frucht-Pery; S Bonini; S Bonini; F Levi-Schaffer
Journal:  J Allergy Clin Immunol       Date:  1998-09       Impact factor: 10.793

9.  Eosinophil infiltration and degranulation in normal human tissue.

Authors:  M Kato; G M Kephart; N J Talley; J M Wagner; M G Sarr; M Bonno; T W McGovern; G J Gleich
Journal:  Anat Rec       Date:  1998-11

10.  Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.

Authors:  U Forssmann; M Uguccioni; P Loetscher; C A Dahinden; H Langen; M Thelen; M Baggiolini
Journal:  J Exp Med       Date:  1997-06-16       Impact factor: 14.307

View more
  8 in total

Review 1.  Eosinophil-mediated tissue inflammatory responses in helminth infection.

Authors:  Myeong Heon Shin; Young Ah Lee; Duk-Young Min
Journal:  Korean J Parasitol       Date:  2009-10       Impact factor: 1.341

2.  Intestinal IFN-γ production is associated with protection from clinical signs, but not with elimination of worms, in Echinostoma caproni infected-mice.

Authors:  Alba Cortes; Javier Sotillo; Carla Muñoz-Antoli; Bernard Fried; J-Guillermo Esteban; Rafael Toledo
Journal:  Parasitol Res       Date:  2014-03-16       Impact factor: 2.289

Review 3.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

Review 4.  Roles and regulation of gastrointestinal eosinophils in immunity and disease.

Authors:  YunJae Jung; Marc E Rothenberg
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422

Review 5.  The Role of Myeloid Cells in Acute Kidney Injury and Kidney Repair.

Authors:  Leyuan Xu
Journal:  Kidney360       Date:  2021-09-22

6.  Longstanding eosinophilic gastroenteritis of more than 20 years.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2009-09       Impact factor: 3.522

7.  Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis.

Authors:  Natalia Schneider Nunes; Saejeong Kim; Maggie Sundby; Parwathy Chandran; Scott Robert Burks; Ana Helena Paz; Joseph Alan Frank
Journal:  World J Gastroenterol       Date:  2018-10-14       Impact factor: 5.742

8.  Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis.

Authors:  Natalia Tiberti; Dora Buonfrate; Carmine Carbone; Geny Piro; Zeno Bisoffi; Chiara Piubelli
Journal:  Parasit Vectors       Date:  2020-10-15       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.